|1.||Tang, Chi-Hui: 1 article (10/2007)|
|2.||Han, Mikyung: 1 article (10/2007)|
|3.||Zheng, Mingzhong: 1 article (10/2007)|
|4.||Grimm, Elizabeth A: 1 article (10/2007)|
|5.||Fokt, Izabela: 1 article (10/2007)|
|6.||Poindexter, Nancy J: 1 article (10/2007)|
|7.||Lee, Sangkyou: 1 article (10/2007)|
|8.||Priebe, Waldemar: 1 article (10/2007)|
|9.||Walch, Eugene T: 1 article (10/2007)|
|10.||Roth, Katherine G: 1 article (10/2007)|
|1.||Melanoma (Melanoma, Malignant)
10/01/2007 - "Our results indicate that WP760 affects a critical and unique set of growth regulatory effects in melanoma, and is a promising candidate for further preclinical studies."
10/01/2007 - "WP760 induced G(2)/M-phase cell-cycle arrest and apoptosis in melanoma cell lines and short-term melanoma explants established from clinical specimens in a time and concentration dependent manner at nM concentrations. "
10/01/2007 - "WP760 initially identified in the NCI 160 screen as anti-melanoma. "
10/01/2007 - "WP760, a melanoma selective drug."
10/01/2007 - "In contrast, effects on fibroblasts and A549 lung cancer cells required higher concentrations, suggesting that WP760 possesses selectivity for melanoma. "
10/01/2007 - "The methyl thiazolyl tetrazolium reduction (MTT) assay was used to test tumor cell growth inhibition; confocal microscopy to view WP760 intracellular distribution; flow cytometry for cell-cycle arrest and apoptosis; and Western blotting was employed to identify and compare quantities and kinetics of cell growth related molecule levels. "
|3.||Lung Neoplasms (Lung Cancer)
|1.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
|2.||Nitric Oxide (Nitrogen Monoxide)